SCHEMBL21393518

SCHEMBL21393518

COCC(=S)c1ncccc1COc1cccc(O)c1C=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C8 P10632 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
ERN1 O75460 3/20 0.34
KDM4E B2RXH2 4/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HTT P42858 2/20 0.33
NPC1 O15118 1/20 0.33
ALOX12 P18054 1/20 0.33
RAB9A P51151 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
GRM4 Q14833 1/20 0.32
DCPS Q96C86 1/20 0.32
BACE1 P56817 4/20 0.31
EGLN2 Q96KS0 1/20 0.31
FTO Q9C0B1 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21383166 0.83 CYP1A2 (0.55) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL23279451 0.78 CYP1A2 (0.52) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL16075540 0.78 CYP1A2 (0.60) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL27188138 0.78 CYP1A2 (0.58) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL23279413 0.77 CYP1A2 (0.51) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22905459 0.77 CYP1A2 (0.57) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL27188166 0.77 CYP1A2 (0.57) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL16710476 0.75 CYP1A2 (0.52) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL16075537 0.75 CYP1A2 (0.52) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL16075536 0.75 CYP1A2 (0.49) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019182938-A1 AROMATIC ALDEHYDES WITH SUSTAINED AND ENHANCED IN VITRO AND IN VIVO PHARMACOLOGIC ACTIVITY TO TREAT SICKLE CELL DISEASE VIRGINIA COMMONWEALTH UNIVERSITY (US) 2019-09-26 WO disclosed